# Intellia Therapeutics, Inc. (NTLA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NTLA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 69.29M | $ -422.56M | $ -405.33M | $ 93.33M | $ 671.39M |
| 2024 | $ 60.83M | $ -545.53M | $ -372.77M | $ 210.20M | $ 871.96M |
| 2023 | $ 39.22M | $ -520.29M | $ -441.23M | $ 115.35M | $ 1.05B |
| 2022 | $ 58.22M | $ -529.72M | $ -437.54M | $ 130.70M | $ 1.24B |
| 2021 | $ 39.29M | $ -318.43M | $ -282.64M | $ 74.02M | $ 1.04B |
| 2020 | $ 73.88M | $ -171.00M | $ -68.15M | $ 39.31M | $ 527.07M |
| 2019 | $ 55.64M | $ -128.47M | $ -142.03M | $ 18.38M | $ 269.88M |
| 2018 | $ 40.19M | $ -112.71M | $ -89.30M | $ 0 | $ 277.92M |
| 2017 | $ 35.18M | $ -90.99M | $ -101.53M | $ 0 | $ 300.60M |
| 2016 | $ 22.67M | $ -43.52M | $ 41.20M | $ 0 | $ 209.84M |
| 2015 | $ 8.49M | $ -17.41M | $ -6.06M | $ 0 | $ 67.36M |
| 2014 | $ 0 | $ -10.45M | $ -4.45M | $ 0 | $ 7.57M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.14 |
| Liabilities / Eq | 0.25 |
| Current Ratio | 5.08 |

## Other views

- [Metrics](https://sponda.capital/en/NTLA.md)
- [Charts](https://sponda.capital/en/NTLA/charts.md)
- [Compare](https://sponda.capital/en/NTLA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.